News

Press release

TempraMed Launches National Brick and Mortar Pharmacy Roll Out, Shipping Products to Maccabi Pharmacies Across Israel

Feb 06, 2026

Download document ⤓

Read more
TempraMed Enters Strategic Media Partnership with Dr. Phil’s Envoy Media, Validating Product Portfolio and Accelerating Market Adoption Across the United States

Feb 02, 2026

Download document ⤓

Read more
TempraMed Launches New Product “VIVI Med", Unlocking New Growth Opportunities in High-Value Biologics and Injectable Medications

Jan 23, 2026

Download document ⤓

Read more
TempraMed Receives Positive Response on Payor Reimbursement Model Driving Significant Return on Investment for Medical Payor Coverage

Jan 14, 2026

Download document ⤓

Read more
TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Jan 12, 2026

Download document ⤓

Read more
TempraMed Receives First Commercial Order from Israel Distributor and Completes Initial Shipment Enabling Entry into National Pharmacy Network

Jan 07, 2026

Download document ⤓

Read more
TempraMed Provides Positive Recap on 2025 and Strategic Outlook for 2026

Jan 02, 2026

Download document ⤓

Read more
TempraMed Deepens Asian Market Penetration with Expanded Distribution Partnership and Meaningful Commercial Order in South Korea

Jan 01, 2026

Download document ⤓

Read more

© 2026 Tempramed • Terms of Use • Privacy Policy • Return Policy • Shipment Delivery

Secure Checkout: secure-amex

secure-amex

secure-mastercard

secure-paypal

secure-applepay

secure-jcb

secure-visa

secure-discover

secure-shoppay

secure-klarna

secure-afterpay

secure-affirm

secure-fsa

secure-hsa

Any information on this website is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Always consult a healthcare professional before making health-related decisions.